Oral Vaccines Industry Research Report 2024

Oral Vaccines Industry Research Report 2024


Summary

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

According to APO Research, the global Oral Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.

The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Oral Vaccines segment by Type

Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Oral Vaccines segment by Application

Public
Private
Oral Vaccines Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Oral Vaccines Sales (2019-2030)
2.2.3 Global Oral Vaccines Market Average Price (2019-2030)
2.3 Oral Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Rotavirus Vaccine
2.3.3 Cholera Vaccine
2.3.4 Oral Polio Vaccine
2.4 Oral Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Public
2.4.3 Private
3 Market Competitive Landscape by Manufacturers
3.1 Global Oral Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Oral Vaccines Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Oral Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Oral Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oral Vaccines, Product Type & Application
3.8 Global Manufacturers of Oral Vaccines, Date of Enter into This Industry
3.9 Global Oral Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Oral Vaccines Product Portfolio
4.1.5 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Oral Vaccines Product Portfolio
4.2.5 GSK Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi Oral Vaccines Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Lanzhou Institute
4.4.1 Lanzhou Institute Company Information
4.4.2 Lanzhou Institute Business Overview
4.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
4.4.5 Lanzhou Institute Recent Developments
4.5 Serum Institute
4.5.1 Serum Institute Company Information
4.5.2 Serum Institute Business Overview
4.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Serum Institute Oral Vaccines Product Portfolio
4.5.5 Serum Institute Recent Developments
4.6 Valneva
4.6.1 Valneva Company Information
4.6.2 Valneva Business Overview
4.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Valneva Oral Vaccines Product Portfolio
4.6.5 Valneva Recent Developments
4.7 Shanghai United Cell
4.7.1 Shanghai United Cell Company Information
4.7.2 Shanghai United Cell Business Overview
4.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
4.7.5 Shanghai United Cell Recent Developments
4.8 Bibcol
4.8.1 Bibcol Company Information
4.8.2 Bibcol Business Overview
4.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Bibcol Oral Vaccines Product Portfolio
4.8.5 Bibcol Recent Developments
4.9 PaxVax
4.9.1 PaxVax Company Information
4.9.2 PaxVax Business Overview
4.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 PaxVax Oral Vaccines Product Portfolio
4.9.5 PaxVax Recent Developments
4.10 Vabiotech
4.10.1 Vabiotech Company Information
4.10.2 Vabiotech Business Overview
4.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Vabiotech Oral Vaccines Product Portfolio
4.10.5 Vabiotech Recent Developments
4.11 Tiantan Biological
4.11.1 Tiantan Biological Company Information
4.11.2 Tiantan Biological Business Overview
4.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Tiantan Biological Oral Vaccines Product Portfolio
4.11.5 Tiantan Biological Recent Developments
4.12 EuBiologics
4.12.1 EuBiologics Company Information
4.12.2 EuBiologics Business Overview
4.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 EuBiologics Oral Vaccines Product Portfolio
4.12.5 EuBiologics Recent Developments
4.13 Panacea Biotec Ltd
4.13.1 Panacea Biotec Ltd Company Information
4.13.2 Panacea Biotec Ltd Business Overview
4.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
4.13.5 Panacea Biotec Ltd Recent Developments
4.14 Bio-Med
4.14.1 Bio-Med Company Information
4.14.2 Bio-Med Business Overview
4.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Bio-Med Oral Vaccines Product Portfolio
4.14.5 Bio-Med Recent Developments
4.15 Halfkin Bio-Pharmaceuticals
4.15.1 Halfkin Bio-Pharmaceuticals Company Information
4.15.2 Halfkin Bio-Pharmaceuticals Business Overview
4.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
4.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 Global Oral Vaccines Market Scenario by Region
5.1 Global Oral Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Oral Vaccines Sales by Region: 2019-2030
5.2.1 Global Oral Vaccines Sales by Region: 2019-2024
5.2.2 Global Oral Vaccines Sales by Region: 2025-2030
5.3 Global Oral Vaccines Revenue by Region: 2019-2030
5.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
5.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
5.4 North America Oral Vaccines Market Facts & Figures by Country
5.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Oral Vaccines Sales by Country (2019-2030)
5.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Oral Vaccines Market Facts & Figures by Country
5.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
5.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Oral Vaccines Market Facts & Figures by Country
5.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Oral Vaccines Sales by Type (2019-2030)
6.1.1 Global Oral Vaccines Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Oral Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Oral Vaccines Revenue by Type (2019-2030)
6.2.1 Global Oral Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Oral Vaccines Price by Type (2019-2030)
7 Segment by Application
7.1 Global Oral Vaccines Sales by Application (2019-2030)
7.1.1 Global Oral Vaccines Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Oral Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Oral Vaccines Revenue by Application (2019-2030)
7.2.1 Global Oral Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Oral Vaccines Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oral Vaccines Value Chain Analysis
8.1.1 Oral Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oral Vaccines Production Mode & Process
8.2 Oral Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oral Vaccines Distributors
8.2.3 Oral Vaccines Customers
9 Global Oral Vaccines Analyzing Market Dynamics
9.1 Oral Vaccines Industry Trends
9.2 Oral Vaccines Industry Drivers
9.3 Oral Vaccines Industry Opportunities and Challenges
9.4 Oral Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings